By increasing the GST on Nicotine Replacement Therapy products, the habit of smoking is not being deterred; it might actually be encouraging it.

TOP INSIGHT
Nicotine Polacrilex gum comes under the 18% slab, as against 11.3% average total indirect tax under the pre-GST regime. This alarming difference in the rates will not help India tackle the menace of tobacco smoking and but would in turn risk higher deaths due to non-communicable diseases
According to Dr. Jagannath P, Former State Consultant for Karnataka, and also worked for a WHO-funded project on National Tobacco Control Program “NRT has been instrumental in aiding innumerable smokers quit the habit. Global health bodies such as WHO and the United States Federal and Drug Administration (US FDA) have also identified NRT as an aid to smoking cessation and recommends it as the first line of treatment. Making NRT expensive would defeat the aim of the government in striving for a healthier nation and enhanced productivity.”
“NRT is an effective and easy aid to help quit smoking. By making NRT accessible to millions in India, we could decrease smoking-related disease burden by successfully mitigating the risks of lung cancer, emphysema, stroke, heart attack and complications in pregnancy. With the usage of Nicotine Replacement Therapy, the mortality rate due to smoking-related diseases would drop drastically within just a few years of quitting smoking, even for long-time smokers.” added Dr. Rajam Iyer, Pulmonologist associated with Bhatia and Hinduja Hospital, Mumbai.
NRT provides small quantities of nicotine to the brain, without exposing the body to other harmful products of tobacco combustion. This small quantity of nicotine helps a smoker overcome the urge to smoke, which in turn helps him quit the habit. Let GST not be a hindrance to India’s Health mission. India’s present & future is primarily dependent on good health. GST should enhance the health seeking behavior of millions and not deter.
Source-Medindia
MEDINDIA




Email










